                            stdClass Object
(
    [post_id] => 1114
    [category_id] => 4
    [id] => 4
    [language_code] => en
    [title] => News
    [description] => News
    [slug] => news
    [meta_title] => News
    [meta_description] => News
    [meta_keyword] => News
    [content] => 
    [parent_id] => 0
    [thumbnail] => 
    [banner] => trang_chu/tt_xn/gioi_thieu_ttxn_gentis_(10).jpg
    [is_featured] => 
    [files] => 
    [style] => 
    [class] => 
    [type] => post
    [order] => 1
    [is_status] => 1
    [created_time] => 2019-08-24 10:39:48
    [updated_time] => 2021-09-07 13:05:32
    [created_by] => 
    [updated_by] => 
    [ratting] => 
    [retionship] => 
    [question] => 
    [url_video] => 
    [link] => 
    [i_con] => 
)
1

GenEva was honored with Top 3 global quality products and services in 2023

Created date : 24-07-2023

Updated date: 22-08-2023

Author: Gentis

On the morning of July 23, 2023, GENTIS' GenEva high-end prenatal screening test was honored to receive the award of Top 3 GLOBAL QUALITY PRODUCTS - SERVICES 2023.

Top 3 Global Quality Products and Services 2023 is a prestigious award held annually with the participation of quality products and services of leading companies and units in Vietnam. The goal is to honor good products and services for consumers. To achieve this award, products and services must meet all quality standards and bring value to society.

GenEva premium prenatal screening test was introduced to the market by GENTIS in 2020, bringing top quality products in the field of obstetrics. GenEva combines next-generation sequencing and a proprietary CE-IVD-certified algorithm that is capable of detecting fetal abnormalities even in cases where the amount of free fetal DNA in the mother's blood is at low levels. low (>1.4%). This results in the lowest technical failure rate (0.1%) and eliminates unnecessary invasive testing like other NIPTs.

With 13 years of experience in genetic analysis, GENTIS has analyzed more than 500,000 samples, serving hundreds of thousands of customers each year. As a partner of prestigious medical organizations in Vietnam, GENTIS continuously cooperates with good medical experts and has a team of highly trained, enthusiastic and dedicated consultants. With 2 large-scale and modern laboratories in Hanoi and Ho Chi Minh City, GENTIS is ready to serve customers and partners.

GENTIS is also a unit in Vietnam that meets ISO 15189: 2012 standard on laboratory quality management for NIPT (GenEva). Moreover, the NIPT test at GENTIS also meets the GenQA international standard.

Not only that, GENTIS is transferred with new generation gene sequencing (NGS) technology, the NextSeq 550 machine has high resolution with more than 20 million readings of samples. GENTIS GenEva test results are quite accurate, up to 99.9%. With modern and advanced technology, medical machinery and a team of doctors and experts trained abroad, GENTIS brings the best quality GenEva premium prenatal screening test.

GenEva is a reliable, non-invasive prenatal screening test that is widely accepted and appreciated by experts. With advantages such as safety for pregnant women and fetuses, easy implementation, high accuracy and speed, GenEva will be a useful test for pregnant women.

The award "Top 3 global quality products and services 2023" is a recognition and encouragement for GenEva to continue to improve day by day to best serve the needs of customers and partners. GENTIS is committed to the quality of high-end prenatal screening tests GenEva in particular and genetic analysis tests in general will be further improved.